生物利用度
药理学
纳米团簇
体内分布
药代动力学
医学
鼻腔给药
腹腔注射
毒性
化学
内科学
生物化学
体外
有机化学
作者
Jinqi Hu,Guanbin Gao,Meng Xiao He,Qiang Yin,Xiaobing Gao,Haixing Xu,Taolei Sun
出处
期刊:Nanomedicine
[Future Medicine]
日期:2020-02-21
卷期号:15 (6): 563-580
被引量:24
标识
DOI:10.2217/nnm-2019-0268
摘要
Aim: To explore the optimal route of gold nanoclusters (AuNCs) administration in mice targeting Parkinson's disease. Materials & methods: Assessing the pharmacokinetic and bioavailability of AuNCs in mice administrated following intravenous, intraperitoneal, gavage and intranasal injection. Investigating the biodistribution of AuNCs in mice by atomic absorption spectrometry and transmission electron microscope. Toxicity assessments of AuNCs were carried out both in cells and in mice. Results: Administration of AuNCs via intraperitoneal injection showed the greatest bioavailability and the longest residence in brain. AuNCs could penetrate blood–brain barrier and be excreted mainly through kidney. No obvious toxicity of AuNCs found in cells and in mice. Conclusion: The optimal route of AuNCs administration in mice targeting Parkinson's disease is intraperitoneal administration.
科研通智能强力驱动
Strongly Powered by AbleSci AI